Telix Pharmaceuticals | TLX - Eigenkapital Und Reserven

Aktienkurs
12.50
Täglich Wechseln
-0.30 -2.34%
Monatlich
35.87%
Jährlich
-56.79%
Q1 Prognose
12.48




Eigenkapital Und Reserven Veränderung Datum
Cochlear AUD 1.94B 12.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Integral Diagnostics AUD 301.71M 1.33M 2024-06
Mayne Pharma AUD 454.19M 93.58M 2024-06
Medical Developments International AUD 54.77M 335K 2025-12
Mesoblast USD 574.68M 22.76M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Pacific Edge NZD 26.9M 811K 2025-12
Paradigm Biopharmaceuticals AUD 6M 15.18M 2025-12
Polynovo AUD 83.14M 121K 2025-12
PYC Therapeutics AUD 147.18M 22.82M 2025-12
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.32B 199.62M 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12